CANNABINOIDS ENHANCE HUMAN B-CELL GROWTH AT LOW NANOMOLAR CONCENTRATIONS

被引:149
作者
DEROCQ, JM
SEGUI, M
MARCHAND, J
LEFUR, G
CASELLAS, P
机构
[1] Department of Immunology, Sanofi Recherche
关键词
CANNABINOID; IMMUNOMODULATION; B-CELL ACTIVATION; CP55,940; TRIANGLE-9-TETRAHYDROCANNABINOL; WIN55212-2;
D O I
10.1016/0014-5793(95)00746-V
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study examined the effect of cannabinoid ligands on human tonsillar B-cells activated either through cross-linking of surface immunoglobulins or ligation of the CD40 antigen. The two synthetic cannabinoids, CP55,940 and WIN55212-2, as well as Delta(9)-tetrahydrocannabinol (THC), the psychoactive component of marijuana, caused a dose-dependent increase of B-cell proliferation and displayed EC(50) at low nanomolar concentrations. This cannabinoid-induced enhancing activity mas inhibited by pertussis toxin which suggested a G-protein-coupled receptor process. In addition, the absence of antagonistic effect of SR141716A, a specific CB1 receptor antagonist, together with the demonstration that human B-cells displayed large amount of CB2 receptor mRNAs, led us to assume that the growth enhancing activity observed on B-cells at very low concentrations of cannabinoids could be mediated through the CB2 receptor.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 25 条
[11]   MARIJUANA COMPONENTS SUPPRESS INDUCTION AND CYTOLYTIC FUNCTION OF MURINE CYTOTOXIC T-CELLS INVITRO AND INVIVO [J].
KLEIN, TW ;
KAWAKAMI, Y ;
NEWTON, C ;
FRIEDMAN, H .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1991, 32 (04) :465-477
[12]   EFFECT OF THE PSYCHOACTIVE METABOLITE OF MARIJUANA, DELTA(9)-TETRAHYDROCANNABINOL (THC), ON THE SYNTHESIS OF TUMOR-NECROSIS-FACTOR BY HUMAN LARGE GRANULAR LYMPHOCYTES [J].
KUSHER, DI ;
DAWSON, LO ;
TAYLOR, AC ;
DJEU, JY .
CELLULAR IMMUNOLOGY, 1994, 154 (01) :99-108
[13]   EFFECTS OF CANNABINOIDS AND COCAINE ON THE MITOGEN-INDUCED TRANSFORMATIONS OF LYMPHOCYTES OF HUMAN AND MOUSE ORIGINS [J].
LUO, YD ;
PATEL, MK ;
WIEDERHOLD, MD ;
OU, DW .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992, 14 (01) :49-56
[14]  
LYNN AB, 1994, J PHARMACOL EXP THER, V268, P1612
[15]   SEARCH FOR ENDOGENOUS LIGANDS OF THE CANNABINOID RECEPTOR [J].
MECHOULAM, R ;
HANUS, L ;
MARTIN, BR .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (08) :1537-1544
[16]   MOLECULAR CHARACTERIZATION OF A PERIPHERAL RECEPTOR FOR CANNABINOIDS [J].
MUNRO, S ;
THOMAS, KL ;
ABUSHAAR, M .
NATURE, 1993, 365 (6441) :61-65
[17]   SR141716A, A POTENT AND SELECTIVE ANTAGONIST OF THE BRAIN CANNABINOID RECEPTOR [J].
RINALDICARMONA, M ;
BARTH, F ;
HEAULME, M ;
SHIRE, D ;
CALANDRA, B ;
CONGY, C ;
MARTINEZ, S ;
MARUANI, J ;
NELIAT, G ;
CAPUT, D ;
FERRARA, P ;
SOUBRIE, P ;
BRELIERE, JC ;
LEFUR, G .
FEBS LETTERS, 1994, 350 (2-3) :240-244
[18]   ANADAMIDE, AN ENDOGENOUS CANNABINOID RECEPTOR AGONIST INHIBITS LYMPHOCYTE-PROLIFERATION AND INDUCES APOPTOSIS [J].
SCHWARZ, H ;
BLANCO, FJ ;
LOTZ, M .
JOURNAL OF NEUROIMMUNOLOGY, 1994, 55 (01) :107-115
[19]   DELTA(9)-TETRAHYDROCANNABINOL (THC) MODULATES IL-1 BIOACTIVITY IN HUMAN-HUMAN MONOCYTE-MACROPHAGE CELL-LINES [J].
SHIVERS, SC ;
NEWTON, C ;
FRIEDMAN, H ;
KLEIN, TW .
LIFE SCIENCES, 1994, 54 (17) :1281-1289
[20]   MARIJUANA AND IMMUNITY - TETRAHYDROCANNABINOL MEDIATED INHIBITION OF LYMPHOCYTE BLASTOGENESIS [J].
SPECTER, S ;
LANCZ, G ;
HAZELDEN, J .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1990, 12 (03) :261-267